Have a personal or library account? Click to login
Detecting EGFR mutations in patients with non-small cell lung cancer Cover

Detecting EGFR mutations in patients with non-small cell lung cancer

Open Access
|Oct 2018

Figures & Tables

Figure 1

Plot shows EGFR positive samples for the exon 19 deletion; amplification of the internal control (Ctrl assay) with CT 26.45 and amplification for mutational assay (del assay) with CT 29.42. ΔCT = 2.97 (calculated by the formula ΔCT = mutation CT-control CT). The ΔCT cutoff value for this mutational assay was 9.06.
Plot shows EGFR positive samples for the exon 19 deletion; amplification of the internal control (Ctrl assay) with CT 26.45 and amplification for mutational assay (del assay) with CT 29.42. ΔCT = 2.97 (calculated by the formula ΔCT = mutation CT-control CT). The ΔCT cutoff value for this mutational assay was 9.06.

Types of the mutations detected_

Mutations DetectedPatients (n)%
Deletions in exon 193156.4
L858R2036.4
Insertions in exon 2023.6
Deletions in exon 19 and T790M11.8
Deletions in exon 19 and S768I11.8

Clinicopathological features of the 551 patients_

Clinicopathological FeaturesTotal Patients (n)Patients with Mutations or Wild-Type (n)p Value
MutationsWild-Type
Gender:
males40716391<0.0001
females14439105
Histology:
adenocarcinomas27641235
other types275142610.000232
Smoking history:
smokers33823315
non smokers213321810.002807
Language: English
Page range: 13 - 17
Published on: Oct 29, 2018
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2018 ZA Hammoudeh, O Antonova, R Staneva, D Nikolova, Y Kyuchukov, A Penev, T Mintchev, V Koleva, S Hadjidekova, D Toncheva, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.